BRPI0515040A - géis de testosterona compreendendo propileno glicol como facilitador de penetração - Google Patents

géis de testosterona compreendendo propileno glicol como facilitador de penetração

Info

Publication number
BRPI0515040A
BRPI0515040A BRPI0515040-0A BRPI0515040A BRPI0515040A BR PI0515040 A BRPI0515040 A BR PI0515040A BR PI0515040 A BRPI0515040 A BR PI0515040A BR PI0515040 A BRPI0515040 A BR PI0515040A
Authority
BR
Brazil
Prior art keywords
propylene glycol
penetration enhancer
testosterone gels
testosterone
gels
Prior art date
Application number
BRPI0515040-0A
Other languages
English (en)
Inventor
Dominique Salin-Drouin
Original Assignee
Besins Int Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292170A external-priority patent/EP1634583A1/en
Application filed by Besins Int Lab filed Critical Besins Int Lab
Publication of BRPI0515040A publication Critical patent/BRPI0515040A/pt
Publication of BRPI0515040B1 publication Critical patent/BRPI0515040B1/pt

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

GéIS DE TESTOSTERONA COMPREENDENDO PROPILENO GLICOL COMO FACILITADOR DE PENETRAçãO. A presente invenção refere-se a géis composições farmacêuticas contendo testosterona, e a métodos que utilizam os mesmos.
BRPI0515040-0A 2004-09-09 2005-09-07 Géis de testosterona compreendendo propileno glicol como intensificador de penetração BRPI0515040B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP04292170A EP1634583A1 (en) 2004-09-09 2004-09-09 Testosterone gels comprising propylene glycol as penetration enhancer
EP04292170.0 2004-09-09
US63836004P 2004-12-23 2004-12-23
US60/638,360 2004-12-23
PCT/EP2005/010293 WO2006027278A1 (en) 2004-09-09 2005-09-07 Testosterone gels comprising propylene glycol as penetration enhancer

Publications (2)

Publication Number Publication Date
BRPI0515040A true BRPI0515040A (pt) 2008-07-01
BRPI0515040B1 BRPI0515040B1 (pt) 2021-10-13

Family

ID=39381985

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515040-0A BRPI0515040B1 (pt) 2004-09-09 2005-09-07 Géis de testosterona compreendendo propileno glicol como intensificador de penetração

Country Status (6)

Country Link
JP (1) JP2008512425A (pt)
BR (1) BRPI0515040B1 (pt)
EA (1) EA013430B1 (pt)
IL (1) IL181583A0 (pt)
MX (1) MX2007002814A (pt)
NZ (1) NZ553446A (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
WO2017057743A1 (ja) * 2015-09-30 2017-04-06 富士フイルム株式会社 経皮吸収用組成物
WO2019088010A1 (ja) * 2017-10-30 2019-05-09 帝國製薬株式会社 経皮投与製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
EP1347764B1 (de) * 2000-12-22 2007-03-14 Dr. August Wolff GmbH & Co. KG Arzneimittel Gelzusammensetzung auf alkoholischer basis zur behandlung von hypogonadismus durch transskrotale applikation
DK1317921T3 (da) * 2001-12-07 2009-12-21 Besins Mfg Belgium Farmaceutisk sammensætning i form af en gel eller oplösning med dihydrotestosteron, fremgangsmåde til fremstilling og anvendelser heraf
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition

Also Published As

Publication number Publication date
HK1099887A1 (en) 2007-08-24
BRPI0515040B1 (pt) 2021-10-13
MX2007002814A (es) 2007-05-16
NZ553446A (en) 2010-05-28
JP2008512425A (ja) 2008-04-24
EA200700580A1 (ru) 2007-08-31
IL181583A0 (en) 2007-07-04
EA013430B1 (ru) 2010-04-30

Similar Documents

Publication Publication Date Title
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
BRPI0914682B8 (pt) compostos de heteroarila e composições compreendendo os referidos compostos
CR11427A (es) 2-fluoro-2 - desoxitetrahidrouridinas como inhibidores de citidina desaminasa
CR9786A (es) Compuestos de bencimidazol-tiofeno
MX346924B (es) Compuestos de diarilhidantoina.
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA200702550A1 (ru) Способ получения эпоксида
CR9253A (es) Fijacion de la dosificacion de anticuerpos her
ECSP11011054A (es) Péptidos antivirales terapéuticos
CR9944A (es) Formulaciones con biodisponibilidad mejorada comprendiendo un derivado de esteroide y un glicerido poliglucosa
EA201170703A1 (ru) Производные адамантилбензамида
NO20082298L (no) Kaliumkanalinhibitorer
BR122018009866B8 (pt) métodos para preparar compostos de éter aminocicloexílico e compostos intermediários
CL2008001048A1 (es) Compuestos derivados de heterociclos nitrogenados; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto como antibacterianos.
EA201201406A1 (ru) Фунгицидные смеси ii, содержащие хиназолины
UA87158C2 (ru) Тестостероновый гель, содержащий пропиленгликоль в качестве усилителя проникающей способности
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
ATE509931T1 (de) Azaadamantanester- und carbamatderivate sowie anwendungsverfahren dafür
GT200400257A (es) Composicion herbicida
AR054937A1 (es) Goma de mascar biodegradable
CL2011001122A1 (es) Compuestos derivados de carbamatos de alquilheterociclos; procedimiento de preparacion; composicion farmaceutica; y su uso para prevenir o tratar dolores agudos o cronicos, patologias neurologicas y psiquiatricas, enfermedades cardiovasculares, entre otras.
BRPI0506888A (pt) composições de suplemento lìquido compreendendo um ou mais medicamentos
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
ECSP088472A (es) Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento
ATE552832T1 (de) Antidepressivum-propharmaka

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL (LU)

B25G Requested change of headquarter approved

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL (LU)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.